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Epstein-Barr virus (EBV)-associated T- or natural killer (NK)-cell lymphoproliferative 
disease (LPD) is a heterogeneous group of disorders characterized by chronic 
proliferation of EBV-infected lymphocytes. Patients may present with severe skin 
manifestations, including hypersensitivity to mosquito bites (HMB) and hydroa 
vacciniforme (HV)-like eruption, which are characterized by blister formation and 
necrotic ulceration. Skin biopsy specimens show inflammatory reactions comprising 
EBV-infected lymphocytes. However, blister fluids have not been fully assessed in 
patients with this disease. Blister fluids were collected from three patients with EBV-
associated LPD: two with HMB and one with HV. Immunophenotyping of blister 
lymphocytes and measurement of tumor necrosis factor (TNF)-α in blister fluids were 
performed. The patients with HMB and HV exhibited markedly increased percentages of 
NK and γδ T cells, respectively, in both peripheral blood and blister fluids. These NK and 
γδ T cells strongly expressed the activation marker HLA-DR and were considered to be 
cellular targets of EBV infections. TNF-α was highly elevated in all blister fluids. Severe 
local skin reactions of EBV-associated LPD might be associated with infiltrating EBV-
infected lymphocytes and a high TNF-α concentration in blister fluids. 
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Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects more than 90% 
of human and persists in B cells for the lifetime of the seropositive normal hosts.1 
Primary EBV infection is usually asymptomatic, but occasionally causes infectious 
mononucleosis, which resolves spontaneously after the emergence of EBV-specific 
immunity. EBV rarely infects T or natural killer (NK) cells in healthy individuals, and 
chronic proliferation of those EBV-infected cells causes EBV-associated T- or NK-cell 
lymphoproliferative diseases (LPD).2 EBV-associated T- or NK-cell LPD shows diverse 
clinical manifestations ranging from localized forms, such as hypersensitivity to mosquito 
bites (HMB) and hydroa vacciniforme (HV) to systemic forms, such as chronic active 
EBV infection (CAEBV).3 
CAEBV is characterized by persistent or recurrent infectious mononucleosis-like 
symptoms and extremely high viral loads in peripheral blood.4, 5 Patients with CAEBV 
typically present with prolonged fever, lymphadenopathy and hepatosplenomegaly. 
Based on the cellular targets of EBV, CAEBV can be divided into T-cell type and NK-
cell type infections, and T-cell type CAEBV is further subdivided into CD4+, CD8+, and 
γδ T cell-type infections.6 Patients with CAEBV may show cutaneous manifestations, 
including HMB or HV-like eruptions.  
HMB is characterized by large erythematous swellings, blister formation and 
necrotic ulcerations after exposure to mosquito bites.7, 8 In patients with HMB, 
vaccinations may precipitate similar cutaneous lesions. HMB has also been associated 
with NK-cell type CAEBV, but rarely with T-cell type CAEBV.9 Patients with HV 
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present with characteristic skin lesions, including vesicle, crust and scar formation, which 
recurrently occur on sun-exposed areas with onset in childhood.10 Some of these patients 
may show systemic manifestations, including fever, lymphadenopathy and liver 
dysfunction, that are associated with T-cell type CAEBV.11 The immunological 
mechanisms leading to local skin reactions such as HMB and HV are largely unknown. In 
this study, we examined skin blister fluids from three children with EBV-associated LPD 







The subjects were three Japanese patients with EBV-associated T- or NK-cell 
LPD. Clinical and immunological data for the patients are shown in Table 1. Patients 1 
and 2 have been described in previous case reports,12, 13 in which these patients were 
referred to as patients 1 and 3, respectively.13 Patient 3 was an 11-year-old boy who 
developed vesicle, crust and scar formation on sun-exposed skin at age 10 years (Figure 
1A). A diagnosis of HV was made at age 11, when skin biopsy specimens showed the 
presence of the EBV genome. There was no history of HMB in this patient. Approval for 
the study was obtained from the Human Research Committee of Kanazawa University 
Graduate School of Medical Science, and informed consent was obtained according to the 
Declaration of Helsinki. 
 
Cell preparation and in situ hybridization for EBV-encoded small RNA1 (EBER1) 
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque 
gradient centrifugation from patients and controls. Peripheral blood lymphocytes (PBLs) 
were prepared from PBMCs by depletion of monocytes using anti-CD14 monoclonal 
antibody (mAb)-coated magnetic beads. CD4+ T, CD8+ T, CD19+ B, and CD56+ NK cells 
were then purified by positive selection from PBLs using mAb-coated magnetic beads.14 
To obtain γδ T cells, PBLs were stained with biotin-conjugated anti-T-cell receptor 
(TCR) γδ mAb, followed by incubation with streptavidin-coated magnetic beads (all from 
Becton Dickinson, San Diego, CA). The purities of the isolated γδ T, CD4+ T, CD8+ T, 
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CD19+ B, and CD56+ NK cells from patient 3 were 98.3, 94.4, 88.4, 80.1, and 86.2%, 
respectively, as determined by flow cytometric analysis. In situ hybridization for EBER-1 
was performed as described previously.14 
 
Flow cytometry 
Blister fluids from the patients were collected into syringes. Flow cytometric 
analysis of blister lymphocytes was performed immediately after sample collection. All 
incubation and washing steps were carried out in ice-cold phosphate-buffered saline. 
After lysis of erythrocytes and washing, stained cells were analyzed with a FACSCalibur 
flow cytometer using CellQuest software (BD Bioscience, Tokyo, Japan).12 HLA-DR was 
used as the activation marker on γδ T or CD56+ NK cells. Blister fluids from three 
children with “simple” mosquito allergy who exhibited erythema and blister formations 
after mosquito bites were utilized as disease controls.15 Despite the presence of blister 
formation, there were no systemic symptoms and no evidence of lymphoproliferative 
diseases in the three controls. 
 
Tumor necrosis factor (TNF)-α measurement 
After centrifugation, blister samples were stored at -80ºC until use. 
Concentrations of TNF-α were determined using an enzyme-linked immunosorbent assay 
kit (R&D Systems, Minneapolis, MN).16 Analysis of significant differences between 
groups was performed using a Student t-test for unpaired samples. A difference with 






Patients 1 and 2 showed typical clinical features of HMB, such as intense local 
skin reactions accompanied by general symptoms including fever and abnormal liver 
function, after mosquito bites (Figure 1A). Patient 3 showed characteristic skin findings 
of HV, but no systemic manifestations of fever, lymphadenopathy or liver dysfunction. 
Serological tests for EBV indicated past infection, and EBV DNA loads in peripheral 
blood were markedly increased in all patients (Table 1). The percentage of EBER-1-
positive cells in the population of PBMCs from patients 1, 2 and 3 were 43.2%, 27.2%, 
and 14.4%, respectively. Ectopic EBV infection of CD56+ NK cells was found in patient 
1 (81.6%),12 whereas the dominant population of EBER-1-positive cells was γδ T cells in 
patient 3 (58.6%), who showed negligible expression of EBER-1 in CD4+ T, CD8+ T, 
CD19+ B, and CD56+ NK cells (Figure 1B). We were unable to analyze the cellular target 
of EBV in patient 2 because no appropriate sample was available. Flow cytometric 
analysis of peripheral lymphocytes showed markedly increased percentages of NK cells 
from patients 1 and 2, and of γδ T cells from patient 3 (Table 1). These NK and γδ T cells 
strongly expressed the activation marker HLA-DR (Figure 2). 
Patients 1 and 2 underwent successful stem cell transplantation at age 8 and 10 
years, and are alive with no evidence of recurrence at age 16 and 14 years, respectively. 
Patient 3 is now 12 years old, and prophylactic care including the use of sunscreens 
effectively reduces the severity of skin reactions. 
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Characterization of skin blister fluids 
Because blisters do not develop on skin in healthy individuals, there are no 
reference values for immunophenotyping of lymphocytes infiltrated into skin blister 
fluids. Therefore, we utilized blister fluids from children with “simple” mosquito allergy 
as controls. Most blister-infiltrated cells were found to be CD203c+ cells, which were 
assumed to be basophils and/or mast cells. Small populations of CD3+ T and CD56+ NK 
cells were also identified in these fluids (Table 2).12 In contrast to the controls with 
mosquito allergy, there were significant increases in the percentages of CD56+ NK cells 
in patients 1 and 2, and of γδ T cells in patient 3. Most of these NK and γδ T cells 
expressed HLA-DR, similarly to circulating NK and γδ T cells in the respective patients 
(Figure 2). An analysis of TNF-α in blister fluids (Figure 3) showed that TNF-α was 
markedly elevated in the patients, but was not elevated in the controls with mosquito 






The clinical features of the three patients in this study were consistent with EBV-
associated LPD. Patient 1 had a diagnosis of NK-cell type CAEBV,12 which represents 
the major type of EBV-associated NK cell-LPD.6 In patient 2, the cellular target of EBV 
infection was not analyzed, but NK-cell type CAEBV was also likely in this case because 
of the presence of NK cell lymphocytosis, high serum IgE levels, and HMB.17 Patient 3 
was diagnosed with HV. This disease is divided into classical and severe HV, both of 
which exhibit a high EBV viral load and increased percentages of γδ T cells in peripheral 
blood.18 Patients with severe HV show systemic manifestations, including fever, 
lymphadenopathy and liver dysfunction, and may progress to malignant lymphoma.19 
Because this condition is closely related to T-cell type CAEBV and it is difficult to 
predict which patients will develop overt lymphoma, the term HV-like lymphoma has 
been changed to HV-like LPD in the 2016 World Health Organization classification of 
lymphoid neoplasms.20 In patient 3, the lack of general symptoms supports the diagnosis 
of classical HV; however, it should be noted that systemic inflammation may behave in 
an indolent fashion.21 
HMB and HV are characterized by severe local skin reactions such as blister 
formation and necrotic ulcerations.3 Blister formation can be due to various causes, 
including inflammation, infection, injury, autoimmune and genetic defects.22, 23 
Accumulation of fluids within the epidermis causes the epidermis to lift and results in 
blister formation in a setting of inflammation and infection. Skin biopsy specimens of 
HMB and HV show inflammatory reactions composed of EBV-infected lymphocytes and 
 10 
reactive lymphocytes.8, 11 Therefore, characterization of blister fluids may allow an 
additional assessment of the local immunological conditions in skin lesions. In this study, 
we found that most blister-infiltrated cells were NK cells in patients 1 and 2, and γδ T 
cells in patient 3, and all these cells were assumed to be infected with EBV. Similarly to 
circulating EBV-infected lymphocytes, these infiltrated cells markedly expressed 
activation marker HLA-DR, suggesting their involvement in severe local skin reactions. 
In addition, blister fluids from the patients had much higher levels of TNF-α compared 
with those from controls with simple mosquito allergy. We did not examine the cellular 
sources of TNF-α production in blister fluids, but the markedly high TNF-α level might 
also be associated with the severe local skin reactions in the patients. From a diagnostic 
point of view, these assessments of skin blister fluids may provide clues that lead to 
diagnosis of EBV-associated T- or NK-cell LPD. 
Careful interpretation of the results of cellular compositions and inflammatory 
cytokines in blister fluids is needed because the time to sampling after blister formation 
may influence the findings. In addition, there is a possibility that peripheral blood can 
contaminate blister fluids. However, blister fluids from the patients had much lower 
percentages of cells that were not infected by EBV, compared to peripheral blood. 
Accordingly, the appearance of NK or γδ T cells in the blister fluids was probably a 
consequence of infiltration of EBV-infected cells, rather than contamination with 
peripheral blood. Other limitations of the study include the small number of patients and 
the small amount of blister fluid, which did not allow performance of multiple cytokine 
analysis and serial flow cytometric analysis. Further studies will be necessary to 
understand the pathogenesis underlying severe local skin reactions in association with 
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EBV infection in patients with EBV-associated LPD. Because sampling of blister fluids 
is less invasive compared to skin biopsy, our approach may be clinically beneficial in 
diagnosis of children with suspected EBV-associated LPD. 
 In summary, this study demonstrated the usefulness of characterization of blister 
fluids and suggests that EBV-infected cells and a high TNF-α level in blister fluids are 
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Table 1.  Patient characteristics 
 
 P1 P2 P3 Normal range 
 
Age at onset (y) 7 8 10 
Age at diagnosis (y) 7 9 11 
Sex Male Male Male 
Symptoms HMB, fever, HMB, fever, Hydroa 
 liver damage liver damage vacciniforme 
WBC (/µL) 7,400 4,990 4,070 4,000-10,500 
Lymphocytes (/µL) 2,310 1,370 2,210 1,500-3,000 
sIL-2R (IU/mL) 2,053 1,929 451 145-519 
Ferritin (µg/L) 152 376 32 25-280 
IgE (IU/mL) 1,055 10,020 633 <696 
EBV titer* 
     VCA-IgG 40 40 80 <10 
     VCA-IgM <10 NA <10 <10 
     EBNA 40 80 20 <10 
EBV DNA loads 1.3x106 2.8x104 2.3x105 <2.0x101 
     (copies/ 106 WBC)  
EBV terminal repeat monoclonal monoclonal NA 
Lymphocyte subsets (%) 
     γδ+ T cells 1.4 1.0 24.8 4.4 ± 2.4 
     CD3+ T cells 36.3 41.9 81.9 69.5 ± 4.6 
     CD4+ T cells 23.1 34.3 30.3 43.1 ± 6.0 
     CD8+ T cells 9.5 15.0 24.4 22.0 ± 5.4 
     CD20+ B cells 3.5 8.5 8.2 11.2 ± 3.5 
     CD56+ NK cells 51.8 38.6 8.5 12.8± 5.3 
     HLA-DR+ cells 60.1 51.7 44.3 NA 
 
* EBV titers were measured by immunofluorescence assay and are expressed as reciprocal 
serum dilutions. EBNA, Epstein-Barr virus nuclear antigen; HMB, hypersensitivity to 
mosquito bites; NA, not available; NK, natural killer; sIL-2R, soluble interleukin-2 
receptor; VCA, viral capsid antigen; WBC, white blood cell. 
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Table 2.  Immunophenotype of lymphocytes in blister fluids 
 
 P1 P2 P3 Mosquito allergy (n=3) 
 
γδ+ T cells NA NA 84.8 2.5 ± 1.4 
CD3+ T cells 11.5 30.6 89.1 15.6 ± 5.5 
CD4+ T cells NA 29.8 2.3 11.5 ± 5.5 
CD8+ T cells NA 2.0 5.2 7.4 ± 7.2 
CD56+ NK cells 66.8 52.9 1.2 7.2 ± 2.8 
CD203c+ cells 5.5 5.6 4.5 62.9 ± 17.8 
 





Figure 1.  Skin lesions and characterization of EBV-infected cells. (a) Intense 
inflammatory skin lesions after mosquito bites (patients 1 and 2) and after sun exposure 
(patient 3). (b) Detection of EBER-1+ cells in γδ T cells, but not in CD4+ T, CD8+ T, 
CD19+ B, and CD56+ NK cells, from patient 3. 
 
Figure 2. Flow cytometric analysis of peripheral blood and skin blister fluids. Peripheral 
blood and blister samples were stained with monoclonal antibodies for anti-CD56 or anti-
TCR Pan γδ together with anti-HLA-DR. 
 
 
Figure 3. Tumor necrosis factor (TNF)-α concentration in blister fluids. Data represent 





















Figure 3  
 
 
 
 
 
